Refoxy Pharma

Berlin, Germany

Developer of therapeutic medicines intended to treat age-related diseases and improve healthy longevity.

$9.6M raised

Dec 2024

Seed

Manufacturing Pharmaceutical Therapeutics

Top Investors

HTGF (High-Tech Gruenderfonds)Boehringer Ingelheim Venture Fund Apollo Health Ventures Korify Capital NRW.Venture

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Refoxy Pharma

How much funding has Refoxy Pharma raised?

Refoxy Pharma has raised $9.6M in total funding. The most recent round was Seed. The last funding was announced in December 2024.

Who are Refoxy Pharma's investors?

Refoxy Pharma's investors include HTGF (High-Tech Gruenderfonds), Boehringer Ingelheim Venture Fund, Apollo Health Ventures, Korify Capital, NRW.Venture.

Where is Refoxy Pharma headquartered?

Refoxy Pharma is headquartered in Berlin, Germany.

What does Refoxy Pharma do?

Developer of therapeutic medicines intended to treat age-related diseases and improve healthy longevity.

What stage is Refoxy Pharma at?

Refoxy Pharma is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated December 4, 2024.

MLA

"Refoxy Pharma — Funding & Investors." VCBacked, December 4, 2024, https://www.vcbacked.co/company/refoxy-pharma. Accessed July 2, 2026.

APA

VCBacked. (2024). Refoxy Pharma — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/refoxy-pharma

Wikipedia (cite web)

{{cite web |title=Refoxy Pharma — Funding & Investors |url=https://www.vcbacked.co/company/refoxy-pharma |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated December 4, 2024.